STAT+: Humana projects a tough road for Medicare Advantage, sinking its stock
Humana’s Medicare Advantage business is faring even worse than the company let on last week,…
Category: Medicine
STAT+: Early detection of pancreatic cancer could get a boost from AI that identifies people at higher risk
Limor Appelbaum has seen too many patients whose first sign of a fatal illness came…
HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14
A historic new study out of Scotland shows the real-world impact of vaccines against the…
STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that…
Two genomics powerhouses team up to expand infectious disease surveillance
LONDON — Two research centers that have been at the forefront of following the evolution…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about fake Ozempic, the FTC policing pharma, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: As biotech VCs struggle to raise money, some debate whether the worst is over
Over the last year or two, something curious has started occurring in the conference rooms…
.jpg)
Opinion: Other states should follow New Jersey’s lead on prior authorization reform
Imagine this scene: You are a cancer patient already navigating fear and uncertainty around your…
STAT+: What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise
Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura…
Transgender women’s higher risk for HIV is influenced by discrimination, CDC finds
Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
‘The response defies belief’: Year of inaction leaves children at risk from bad cancer drugs
A year after an investigation revealed widespread use of a substandard cancer drug, the World…
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
STAT+: Osteoarthritis might be linked to protein known for its role in Alzheimer’s, study says
A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of…
New chronic Covid study offers insight into which immunocompromised patients are most at risk
You’ve heard of long Covid, a condition in which the acute infection subsides but troubling…
STAT+: Pharmalittle: We’re reading about Lilly’s gene therapy for hearing, Shkreli’s life-long ban, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
As NIH grant runs out, Dog Aging Project founders look to raise up to $50 million
The Dog Aging Project, which researchers say could yield promising leads for human longevity research,…
STAT+: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices
The chemical used to sterilize half of all medical devices in the United States is…
Opinion: Defunding liberal arts is dangerous for health care
If you want an argument in favor of teaching the humanities, I suggest you ask…
Opinion: After 20 years in rehabilitation research, my young daughter’s traumatic brain injury transformed my mind and my career
In the spring of 2020, my almost 4-year-old daughter Livie sustained a severe traumatic brain…
STAT+: A for-profit health system’s financial issues could plunge overburdened hospitals into crisis
Steward Health Care, a for-profit health system that serves thousands of patients in Eastern Massachusetts,…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Mammograms are less effective for women with dense breast tissue. Medical experts disagree on what to do about it
Millions of American women over age 40 receive regular mammograms to screen for breast cancer….
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
The White House has a pharmacy — and it’s been a mess, a new investigation found
There’s a pharmacy in the White House — or, at least, there’s a sign that…
Opinion: It’s time to remove skin color from the Apgar Score for newborns
In medicine, inertia can be a strangely powerful force, but Virginia Apgar never succumbed to…
Abortion funds run short of money as demand soars and donations fall
The head of the Abortion Fund of Ohio had a sinking feeling as she looked…
STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline
LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday…
Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data
A review of alleged data manipulation in studies involving four top scientists at Dana-Farber Cancer…
Medicare Advantage update pushes Wall Street to reset expectations
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
New tool for tracing blood cells’ ancestry might one day help predict disease risk
The human blood system is in a constant state of turnover. First-line immune defenders, like…
STAT+: Pharmalittle: We’re reading about Lilly plant problems, FDA reorganization plans, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs
Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy,…
Opinion: STAT+: Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit
Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions…
Opinion: The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs
In June, the Food and Drug Administration issued a warning letter about advertisements for the…
STAT+: A Harvard course seeks to put food on the table in medical education
BOSTON — Doctors often don’t have a lot of time to chat with patients during…
STAT+: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer…
Why many more people are lining up for a flu shot than a Covid vaccine
America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first…
STAT+: Physician buy-in will make or break VC firm General Catalyst’s bold hospital deal
It makes sense in theory for hospitals and startups to strike deals. Not only would…
STAT+: FDA sets aggressive deadline for inspection overhaul
WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul…
Rollout of a new malaria vaccine kicks off in Africa
LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for…
STAT+: Dana-Farber cancer researchers moving to retract one paper, correct others in broad investigation of manipulated data
Scientists at Dana-Farber Cancer Institute, one of the nation’s leading cancer research and treatment centers,…
STAT+: FDA scolds Novartis over a misleading TV ad for a breast cancer treatment
The U.S. Food and Drug Administration scolded Novartis for making false and misleading statements about…
Feds bar Theranos founder Elizabeth Holmes from government health programs
WASHINGTON — Theranos founder and ex-CEO Elizabeth Holmes is banned from federal health programs for…
STAT+: Pharmalittle: We’re reading about Sanders targeting pharma CEOs, insider trading, and more
And so, another working week will soon draw to a close. Not a moment too…